RELATIONSHIP BETWEEN C-ERBB-2 IMMUNOREACTIVITY AND THYMIDINE LABELING INDEX IN BREAST-CARCINOMA INSITU

被引:48
|
作者
BARNES, DM
MEYER, JS
GONZALEZ, JG
GULLICK, WJ
MILLIS, RR
机构
[1] ST LUKES HOSP,CHESTERFIELD,MO
[2] JEWISH HOSP ST LOUIS,ST LOUIS,MO 63110
[3] WASHINGTON UNIV,SCH MED,ST LOUIS,MO 63110
[4] HAMMERSMITH HOSP,IMPERIAL CANC RES FUND,MOLEC ONCOL GRP,LONDON W12 0HS,ENGLAND
关键词
C-ERBB-2; IMMUNOHISTOCHEMISTRY; THYMIDINE LABELING INDEX; BREAST CARCINOMA INSITU;
D O I
10.1007/BF01975438
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The relationship between the presence of the c-erbB-2 protein, demonstrated immunohistochemically with antibody 21N, and thymidine labelling index (TLI) has been studied in the in situ component of 70 cases of carcinoma of the breast. A significant association was found between high TLI and positive staining. Twenty of the 70 cases stained (29%) and of those that were stained 75% had a high TLI; 43% of those with a high TLI stained positively but only 14% of those with a low TLI stained positively. Strong correlations were seen between nuclear size and histological pattern and both 21N staining and TLI. The majority of carcinomas of comedo pattern with large nuclei were 21N positive and had a high TLI, whilst those with small nuclei and a predominantly cribriform/micropapillary appearance did not stain and had a low TLI. In tumours of mixed histological pattern there was less concordance between staining and TLI. The significance of these findings in relation to the biological behaviour of these tumours and their clinical management is discussed.
引用
下载
收藏
页码:11 / 17
页数:7
相关论文
共 50 条
  • [41] THE RELATIONSHIP BETWEEN HORMONE RECEPTORS AND AMPLIFICATION OF THE C-ERBB-2 ONCOGENE IN BREAST-CANCER
    TODD, DM
    KLIMEK, VM
    DEBARI, VA
    RUBIN, AD
    CLINICAL CHEMISTRY, 1990, 36 (06) : 1061 - 1061
  • [42] Serial serum c-erbB-2 levels in patients with breast carcinoma
    Volas, GH
    Leitzel, K
    Teramoto, Y
    Grossberg, H
    Demers, L
    Lipton, A
    CANCER, 1996, 78 (02) : 267 - 272
  • [43] Relationship of histologic grade, c-erbB-2 expression, and inflammatory infiltrate to prognosis in carcinoma of the breast - In reply
    Menard, S
    Pupa, SM
    Casalini, P
    Rilke, F
    Colnaghi, MI
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (08) : 2407 - 2407
  • [44] CHROMOSOME 11Q13, C-ERBB-2, AND C-MYC AMPLIFICATION IN INVASIVE BREAST-CARCINOMA - CLINICOPATHOLOGICAL CORRELATIONS
    GAFFEY, MJ
    FRIERSON, HF
    WILLIAMS, ME
    MODERN PATHOLOGY, 1993, 6 (06) : 654 - 659
  • [45] C-ERBB-2 IMMUNOREACTIVITY IN LOCALIZED HIGH-GRADE TRANSITIONAL CELL-CARCINOMA
    SWANSON, PE
    FRIERSON, HF
    WICK, MR
    LABORATORY INVESTIGATION, 1992, 66 (01) : A60 - A60
  • [46] C-ERBB-2 ONCOPROTEIN IN SCREEN-DETECTED BREAST-CARCINOMA - AN IMMUNOHISTOLOGICAL STUDY (VOL 55, PG 63, 1993)
    SOOMRO, S
    TAYLOR, P
    SHEPARD, HM
    FELDMANN, M
    SINNETT, M
    SHOUSHA, S
    INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (03) : 462 - 462
  • [47] C-ERBB-2 IN COLORECTAL-CARCINOMA
    ARNAOUT, AH
    DAWSON, PM
    SHOUSHA, S
    SOOMRO, S
    THEODOROU, NA
    TAYLOR, P
    SHEPARD, HM
    FELDMAN, M
    JOURNAL OF PATHOLOGY, 1991, 163 (02): : A176 - A176
  • [48] Is there a relationship between c-erbB-1 and c-erbB-2 amplification and protein overexpression in NSCLC?
    Meert, AP
    Martin, B
    Verdebout, JM
    Noël, S
    Ninane, V
    Sculier, JP
    LUNG CANCER, 2005, 47 (03) : 325 - 336
  • [49] Is there a relationship between FDG uptake and hormone receptors and expression of c-erbB-2 in patients with breast cancer?
    Sanli, Y.
    Karanlik, H.
    Isik, G.
    Turkmen, C.
    Kuyumcu, S.
    Ozturk, B.
    Yavuz, E.
    Mudun, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S357 - S357
  • [50] DISTINCT RESPONSES OF PROTEIN-KINASE-C ISOZYMES TO C-ERBB-2 ACTIVATION IN SKBR-3 HUMAN BREAST-CARCINOMA CELLS
    DISATNIK, MH
    WINNIER, AR
    MOCHLYROSEN, M
    ARGEAGA, CL
    CELL GROWTH & DIFFERENTIATION, 1994, 5 (08): : 873 - 880